CLIN

Clinigen (CLIN)

Company name:Clinigen Group Plc
COD:CLINTrading Currency:GBX
Market Sector:AS50ISIN:GB00B89J2419
Market Segment:AMSMShare Type:DE
WWW Address:http://www.clinigen.co.uk/investorsDescription:ORD 0.1P
Industry Sector:PHARMACEUTICALS & BIOTECHNOLOGY
 Price Variação [%] Bid Offer Abertura MAX MIN Volume
 607.00 images.advfn.com/imagesnew/2/br/up 9.0 [1.51] 606.00 607.00 576.50 607.00 541.50 2,845,113
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52 Semanas
 809.54 133.37 0.29 22.80 6.85 26.62 1.13 881.00 - 541.50

Clinigen Key Figures

Key Figures
(at previous day's close)
Market Cap.809.54m
Shares In Issue133.37m
Prev. Close598.00
PE Ratio26.62 
Dividend Yield1.13%
EPS - basic22.80p
Dividend PS6.85p
Dividend Cover3.33 
Cash Flow PS33.89p
Return On Equity (ROE)6.78%
Operating Margin9.89%
PEG Factor0.22 
EPS Growth Rate121.36%
Dividends PS Growth Rate-9.99%
Dívida Líquida535.70m
Gross Gearing58.05%
Quick Assets256.90m
Net Working Capital140.70m
Intangibles / Fixed Assets95.51%
Turnover PS392.60p
Pre-Tax Profit PS38.84p
Retained Profit PS15.15p
Cash PS62.16p
Net Cash PS-67.41p
Net Tangible Asset Value PS *-203.42p
Net Asset Value PS335.17p
Spread1.00 (0.16%) 

Clinigen Balance Sheet

%1$s Balance Sheet
L^CLIN:Liabilities+EQL^CLIN:Assets

Share Price Performance

Share Price Performance
Sample Period MAXMIN
1 Semana620.50541.50
4 Semanas633.00541.50
12 Semanas734.00541.50
1 Ano881.00541.50

Share Price Chart (5 years)

Share Price Chart (5 years)

Clinigen Historic Returns

%1$s Historic Returns
Período AberturaVAB%Abertura MédiaVol Diário Médio [m]Volume [m]VWAP
1 Semana602.005.000.83541.500.39594.50
4 Semanas605.002.000.33541.500.49600.57
12 Semanas639.50-32.50-5.08541.500.77631.06
26 Semanas810.00-203.00-25.06541.500.92619.30
1 Ano647.50-40.50-6.25541.500.63652.07
3 Anos913.00-306.00-33.52350.400.46718.43
5 Anos770.00-163.00-21.17350.400.42795.93

Clinigen Key Management Ratios

DEEPER ANALYSIS

Clinigen Investment Ratios

%1$s Investment Ratios
(Market value analysis) at previous day's close
PQ Ratio82.90 
PE Ratio26.62 
Tobin's Q Ratio 0.73 
Tobin's Q Ratio (excl. intangibles)2.38 
Dividend Yield1.13%
Market-to-Book Ratio1.81 
Price-to-Pre-Tax Profit PS15.63 
Price-to-Retained Profit PS40.08 
Price-to-Cash Flow PS17.91 
Price-to-Sales PS1.55 
Price-to-Net Tangible Asset Value PS-2.98 
Price-to-Cash PS9.77 
Net Working Capital PS105.50 
Price Pct to Working Capital PS5.75%
Earnings Yield3.76%
Average PE131.73 
Years in average5 
PE to PE average20.21%

Clinigen Financial Ratios

%1$s Financial Ratios
(Leverage Ratios)
Debt Ratio49.93%
Debt-to-Equity Ratio1.00 
Debt-to-Equity Ratio (excl. Intgbl)-1.64 
Debt-to-Equity Market Value0.55 
Net Gearing50.27%
Net Gearing (excl. Intangibles)154.25%
Gross Gearing58.05%
Gross Gearing (excl. Intangibles)178.12%
Gearing Under 1 Year16.22%
Gearing Under 1 Year (excl. Intgbl)49.76%
Assets/Equity2.38 
Cash/Equity18.55 
(Liquidity Ratios)
Net Working Capital to Total Assets13.20%
Current Ratio1.81 
Quick Ratio (Acid Test)1.49 
Liquidity Ratio0.48 
Cash & Equiv/Current Assets26.44%
(Solvency Ratios)
Enterprise Value1,172.44m
CFO/Sales0.09 
CFO/Attributable Profit1.49 
CFO/Assets0.04 
CFO/Debt0.07 
Total Debt/Equity Market Value0.76 
Total Debt/Sales1.18 
Total Debt/Pre-Tax Profit11.94 
Total Debt618.60m
Total Debt/Net Current Assets4.40%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth78.63%
5 yr Compound Earnings Growth47.19%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs3 
Beta coefficients
Beta (60-Mnth)Beta (36-Mnth)
0.29240.2049

Clinigen Operating Ratios

%1$s Operating Ratios
(Profitability Ratios)
Return On Capital Employed (ROCE)5.80%
Return On Assets (ROA)2.75%
Net Profit Margin5.79%
Assets Turnover0.47 
Return On Equity (ROE)6.78%
Return On Investment (ROI)3.31%
Dividend Payout Ratio30.04%
Plowback Ratio69.96%
Growth from Plowback Ratio4.75%
Net Income Of Revenues3.86%
(Asset Utilisation Multiples)
Shareholders Equity Turnover1.17 
Fixed Assets Turnover0.67 
Current Assets Turnover1.65 
Net Working Capital Turnover 
Inventory Turnover10.46 
(Other Operating Ratios)
Total Assets-to-Sales2.11 
Debtors-to-Sales29.33%
Debt Collection Period107.04Dias

Clinigen Dividends

%1$s Dividends
DataTypeCurr.Dividend AmountPeriod StartPeriod EndEx DateRecord DatePayment DateTotal Dividend Amount
16 Set 2021FinalGBX4.7030/06/202030/06/202102/12/202103/12/202104/01/20226.85
23 Fev 2021InterimGBX2.1501/07/202031/12/202018/03/202119/03/202113/04/2021-
17 Set 2020FinalGBX5.4630/06/201930/06/202005/11/202006/11/202002/12/20207.61
25 Fev 2020InterimGBX2.1501/07/201931/12/201919/03/202020/03/202017/04/2020-
19 Set 2019FinalGBX4.7530/06/201830/06/201907/11/201908/11/201929/11/20196.70
27 Fev 2019InterimGBX1.9501/07/201831/12/201821/03/201922/03/201912/04/2019-
27 Set 2018FinalGBX3.8430/06/201730/06/201808/11/201809/11/201830/11/20185.60
27 Fev 2018InterimGBX1.7601/07/201731/12/201722/03/201823/03/201812/04/2018-
28 Set 2017FinalGBX3.4030/06/201630/06/201709/11/201710/11/201701/12/20175.00
15 Mar 2017InterimGBX1.6001/07/201631/12/201623/03/201724/03/201713/04/2017-
28 Set 2016FinalGBX2.7030/06/201530/06/201603/11/201604/11/201625/11/20164.00
02 Mar 2016InterimGBX1.3001/07/201531/12/201517/03/201618/03/201608/04/2016-
22 Set 2015FinalGBX2.3030/06/201430/06/201515/10/201516/10/201506/11/20153.40
03 Mar 2015InterimGBX1.1001/07/201431/12/201412/03/201513/03/201502/04/2015-
24 Set 2014FinalGBX2.1030/06/201330/06/201415/10/201417/10/201407/11/20143.10
26 Fev 2014InterimGBX1.0001/07/201331/12/201305/03/201407/03/201428/03/2014-
25 Set 2013FinalGBX2.0030/06/201230/06/201309/10/201311/10/201301/11/20132.60
27 Fev 2013InterimGBX0.6001/07/201231/12/201206/03/201308/03/201328/03/2013-

Clinigen Fundamentals

Profit and Loss Account
 30 Jun 2018 (GBP)30 Jun 2019 (GBP)30 Jun 2020 (GBP)30 Jun 2021 (GBP)
turnover381.20100.00%456.90100.00%504.30100.00%523.60100.00%m
pre tax profit35.909.42%12.302.69%22.604.48%51.809.89%m
attributable profit27.407.19%5.201.14%13.702.72%30.305.79%m
retained profit21.105.54%-2.50-0.55%4.500.89%20.203.86%m
eps - basic (p)22.90 4.00 10.30 22.80 
eps - diluted (p)22.50 4.00 10.20 22.30 
dividends per share5.60 6.70 7.61 6.85 

Clinigen Balance Sheet

Balance Sheet
 30 Jun 2018 (GBP)30 Jun 2019 (GBP)30 Jun 2020 (GBP)30 Jun 2021 (GBP)
L^CLIN:Liabilities+EQL^CLIN:AssetsL^CLIN:Liabilities+EQL^CLIN:AssetsL^CLIN:Liabilities+EQL^CLIN:AssetsL^CLIN:Liabilities+EQL^CLIN:Assets
 30 Jun 2018 (GBP)30 Jun 2019 (GBP)30 Jun 2020 (GBP)30 Jun 2021 (GBP)
ASSETS
fixed assets fixed assets6.801.02%13.601.28%13.401.17%32.703.07%m
intangibles intangibles497.6074.59%811.9076.16%808.7070.81%718.3067.41%m
fixed investments fixed investments6.600.99%8.700.82%0.200.02%1.100.10%m
current assets - other current assets - other--%--%--%--%m
stocks stocks21.303.19%35.403.32%43.503.81%56.605.31%m
debtors debtors98.5014.77%113.0010.60%133.1011.65%174.0016.33%m
cash & securities cash & securities36.305.44%83.507.83%143.1012.53%82.907.78%m
TOTAL667.10100%1,066.10100%1,142.00100%1,065.60100%m
LIABILITIES
creditors - short creditors - short113.8017.06%243.4022.83%203.2017.79%172.8016.22%m
creditors - long creditors - long203.8030.55%384.3036.05%493.2043.19%445.8041.84%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
TOTAL317.6047.61%627.7058.88%696.4060.98%618.6058.05%m
EQUITY
ord cap, reserves ord cap, reserves349.5052.39%438.4041.12%445.6039.02%447.0041.95%m
prefs, minorities prefs, minorities--%--%--%--%m
TOTAL349.5052.39%438.4041.12%445.6039.02%447.0041.95%m
OTHER
NAV Basic- - - - 
NAV Diluted- - - - 

Clinigen Cash Flow Statement

%1$s Cash Flow Statement
30 Jun 2018 (GBP)30 Jun 2019 (GBP)30 Jun 2020 (GBP)30 Jun 2021 (GBP)
Operating CF47.6068.3060.6045.20m
Pre-Financing CF-75.60-183.00-20.80-15.30m
Retained CF8.8046.8057.10-54.20m

Clinigen Brokers

Broker infomation is not available for this class of stock.
Seu Histórico Recente
LSE
CLIN
Clinigen
Registre-se agora para acompanhar essas ações ao vivo no Monitor ADVFN.

O Monitor permite ver até 110 de suas ações favoritas de uma vez só e é completamente grátis para você usar.

Cotações da NYSE e AMEX têm defasagem de no mínimo 20 minutos.
Quaisquer outras cotações têm defasagem de no mínimo 15 minutos quando não especificado.
Em caso de dúvidas por favor entre em contato com o suporte: suporte@advfn.com.br ou (11) 4950 5808.

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

P: V:br D:20211201 12:36:59